4.8 Article

Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis

期刊

ONCOGENE
卷 30, 期 13, 页码 1566-1576

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2010.532

关键词

ovarian cancer; alpha(5)beta(1)-integrin; c-Met; Src; FAK; fibronectin

资金

  1. Facet Biotech Corp.
  2. Burroughs Wellcome Fund
  3. Ovarian Cancer Research Fund
  4. NCI [RO1 CA111882]

向作者/读者索取更多资源

The role of the fibronectin receptor, alpha(5)beta(1)-integrin, as an adhesion receptor and in angiogenesis is well established. However, its role in cancer cell invasion and metastasis is less clear. We describe a novel mechanism by which fibronectin regulates ovarian cancer cell signaling and promotes metastasis. Fibronectin binding to alpha(5)beta(1)-integrin led to a direct association of alpha(5)-integrin with the receptor tyrosine kinase, c-Met, activating it in a hepatocyte growth factor/scatter factor (HGF/SF) independent manner. Subsequently, c-Met associated with Src, and activated Src and focal adhesion kinase (FAK). Inhibition of alpha(5)beta(1)-integrin decreased the phosphorylation of c-Met, FAK and Src, both in vitro and in vivo. Independent activation of c-Met by its native ligand, HGF/SF, or overexpression of a constitutively active FAK in HeyA8 cells could overcome the effect of alpha(5)beta(1)-integrin inhibition on tumor cell invasion, indicating that alpha(5)beta(1)-integrin is upstream of c-Met, Src and FAK. Inhibition of alpha(5)beta(1)-integrin on cancer cells in two xenograft models of ovarian cancer metastasis resulted in a significant decrease of tumor burden, which was independent of the effect of alpha(5)beta(1)-integrin on angiogenesis. These data suggest that fibronectin promotes ovarian cancer invasion and metastasis through an alpha(5)beta(1)-integrin/c-Met/FAK/Src-dependent signaling pathway, transducing signals through c-Met in an HGF/SF-independent manner. Oncogene (2011) 30, 1566-1576; doi: 10.1038/onc.2010.532; published online 29 November 2010

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据